Your browser doesn't support javascript.
loading
A first-in-class fully modified version of miR-34a with outstanding stability, activity, and anti-tumor efficacy.
Abdelaal, Ahmed M; Sohal, Ikjot S; Iyer, Shreyas; Sudarshan, Kasireddy; Kothandaraman, Harish; Lanman, Nadia A; Low, Philip S; Kasinski, Andrea L.
Afiliação
  • Abdelaal AM; Department of Biological Sciences, Purdue University, West Lafayette, IN, 47907, USA.
  • Sohal IS; Department of Biological Sciences, Purdue University, West Lafayette, IN, 47907, USA. isohal@purdue.edu.
  • Iyer S; Department of Biological Sciences, Purdue University, West Lafayette, IN, 47907, USA.
  • Sudarshan K; Department of of Chemistry, Purdue University, West Lafayette, IN, 47907, USA.
  • Kothandaraman H; Purdue Institute for Cancer Research, Purdue University, West Lafayette, IN, 47907, USA.
  • Lanman NA; Purdue Institute for Cancer Research, Purdue University, West Lafayette, IN, 47907, USA.
  • Low PS; Department of Comparative Pathobiology, Purdue University, West Lafayette, IN, 47907, USA.
  • Kasinski AL; Department of of Chemistry, Purdue University, West Lafayette, IN, 47907, USA.
Oncogene ; 42(40): 2985-2999, 2023 09.
Article em En | MEDLINE | ID: mdl-37666938
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: MicroRNAs / Neoplasias Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: MicroRNAs / Neoplasias Idioma: En Ano de publicação: 2023 Tipo de documento: Article